Amphastar Pharmaceuticals Inc (AMPH)
44.55
+0.46
(+1.04%)
USD |
NASDAQ |
Nov 21, 16:00
44.54
-0.01
(-0.02%)
Pre-Market: 20:00
Amphastar Pharmaceuticals Gross Profit Margin (Quarterly): 53.31% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 53.31% |
| June 30, 2024 | 52.18% |
| March 31, 2024 | 52.43% |
| December 31, 2023 | 53.98% |
| September 30, 2023 | 60.04% |
| June 30, 2023 | 49.92% |
| March 31, 2023 | 52.73% |
| December 31, 2022 | 52.71% |
| September 30, 2022 | 48.71% |
| June 30, 2022 | 51.31% |
| March 31, 2022 | 46.38% |
| December 31, 2021 | 46.52% |
| September 30, 2021 | 45.62% |
| June 30, 2021 | 46.60% |
| March 31, 2021 | 43.63% |
| December 31, 2020 | 38.40% |
| September 30, 2020 | 43.76% |
| June 30, 2020 | 38.67% |
| March 31, 2020 | 43.48% |
| December 31, 2019 | 40.03% |
| September 30, 2019 | 43.99% |
| June 30, 2019 | 40.97% |
| March 31, 2019 | 38.73% |
| December 31, 2018 | 38.68% |
| Date | Value |
|---|---|
| September 30, 2018 | 38.73% |
| June 30, 2018 | 36.69% |
| March 31, 2018 | 29.07% |
| December 31, 2017 | 33.92% |
| September 30, 2017 | 35.49% |
| June 30, 2017 | 41.03% |
| March 31, 2017 | 40.28% |
| December 31, 2016 | 31.42% |
| September 30, 2016 | 42.99% |
| June 30, 2016 | 46.62% |
| March 31, 2016 | 41.95% |
| December 31, 2015 | 43.13% |
| September 30, 2015 | 27.52% |
| June 30, 2015 | 24.73% |
| March 31, 2015 | 23.34% |
| December 31, 2014 | 21.40% |
| September 30, 2014 | 19.75% |
| June 30, 2014 | 30.60% |
| March 31, 2014 | 27.27% |
| December 31, 2013 | 35.77% |
| September 30, 2013 | 34.19% |
| June 30, 2013 | 43.97% |
| March 31, 2013 | 36.93% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
38.40%
Minimum
Dec 2020
60.04%
Maximum
Sep 2023
48.02%
Average
47.65%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| BridgeBio Pharma Inc | 78.11% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.56% |
| Return on Assets | 10.28% |
| Return on Invested Capital | 12.41% |
| Profit Margin (Quarterly) | 21.14% |
| Operating Margin (Quarterly) | 29.83% |
| Return on Net Operating Assets | 13.44% |